PRevention Using EPA Against coloREctal Cancer

ABSTRACT: This research study is evaluating the effect of AMR101 as a possible chemopreventive agent to reduce risk of colorectal cancer in individuals with a history of colorectal adenoma. - The name of the study drug involved in this study is: -- AMR101 (VASCEPA).

DISEASE(S): Colorectal Adenoma,Gastrointestinal Microbiome,Colorectal Cancer,Colorectal Neoplasms,Endoscopic Surgery,Adenoma,Eicosapentaenoic Acid

PROVIDER: 2326011 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR